Brian Doughty

Mr. Doughty brings over 19 years of experience in the healthcare field to Armis Biopharma. He joined the company in 2016 as a consultant focused on market research, disease epidemiology and operational systems and processes and is progressing towards joining Armis as a full time COO. In 2012 Mr. Doughty founded Delta Force Group Inc., a consulting firm specializing in all aspects of business performance in both established firms and start-ups where he led teams of over 200 people responsible for sales, marketing, clinical research and operational functions.

Previously Mr. Doughty served as Vice President of Commercial Operations at Cardiovascular Systems Inc. (NASDAQ: CSII) (2007–2013), as Marketing Director at EKOS Inc. (2006–2007) which was purchased by BTG Interventional Medicine (LSE: BTG.L) for $180M, as National Marketing Manager at Fox Hollow Technologies (2005–2006) which was purchased by Medtronic, as Director of Sales Operations at Medtronic (NYSE: MDT) (2000–2005) and as a sales professional at Johnson & Johnson (NYSE: JNJ) (1998–2000). The total market value of the two start-up entities where he previously served (Fox Hollow Technologies & Cardiovascular Systems Inc.) that were pre-revenue and ultimately went public, reached over $1.8B in market cap during his work.

Mr. Doughty holds a B.S. in public administration (1985), a M.P.A. (1990) from Oakland University, and an M.B.A from Michigan State University (1997).